Equities

Celcuity Inc

CELC:NAQ

Celcuity Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)15.85
  • Today's Change0.12 / 0.76%
  • Shares traded870.86k
  • 1 Year change+54.48%
  • Beta0.7970
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Celcuity Inc (CELC:NAQ) closed at 15.85, 56.00% above the 52 week low of 10.16 set on Nov 08, 2023.
52-week range
Today
10.16Nov 08 202322.19Mar 28 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open15.75
High16.09
Low15.33
Bid15.10
Offer16.65
Previous close15.73
Average volume221.59k
Shares outstanding37.03m
Free float32.20m
P/E (TTM)--
Market cap586.93m USD
EPS (TTM)-2.74
USD
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼

Events & Activity

  • CELC:NAQ trading volume exceeds daily average by +77.40%
  • CELC:NAQ price rises above 200-day moving average to 16.52 at 09:46 GMT
  • CELC:NAQ price moved over +5.98% to 16.14
  • CELC:NAQ price rises above 50-day moving average to 16.14 at 10:04 GMT
  • CELC:NAQ price falls below 50-day moving average to 15.13 at 10:10 GMT
  • CELC:NAQ price rises above 15-day moving average to 15.75 at 09:30 GMT
  • CELC:NAQ price falls below 15-day moving average to 15.66 at 14:39 GMT
  • CELC:NAQ price rises above 15-day moving average to 16.14 at 10:04 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.